The world celebrates the global week of glucoma this week, and plays The periodic examinations of the eye are an important role in the early detection of this disease, especially for those over the age of 40 years or who have a genetic history of the disease, injuries, or previous eye surgeries.
The Hamad Medical Corporation in Qatar said – in a statement to Al -Jazeera Net – that it is participating in the celebration of the International Week of Glucoma by raising the level of awareness of this disease, which affects the eye, and focus on the high -quality services provided by the Foundation to glucoma patients.
Glucoma is a common disease that affects the eye and can lead to permanent vision loss if timely diagnosis and treatment are not carried out, and it occurs when the optic nerve that connects the eye to the brain is damaged as a result of increased eye pressure.
Dr. Zakia Al -Ansari, consultant ophthalmology and head of the Glucoma Unit at Hamad Medical Corporation, explains, “Glucoma is called a hidden sight because it can double without observing the symptoms in the early stages, and periodic tests of the eye are very important to detect the disease early, and reduce the permanent loss of vision.”
The Hamad Foundation called for priority to eye health through periodic detection, especially for individuals who are more likely to infection, such as people over the age of 40 years, who have a genetic history of the disease, previous eye injuries and previous eye surgeries or diseases, people of African, Asian or descended from the Iberian Peninsula, and patients with chronic diseases such as diabetes and shortness or no -sightedness.
The Hamad Foundation recommends the most vulnerable to glucoma to conduct an examination at the age of 35 years, and a comprehensive examination of the eye should be re-examined after 1-3 years, depending on the level of danger and general health of the eye.
The treatment of glucoma in the Hamad Corporation is often provided by using drops that help relieve eye pressure, either by improving fluid drainage or reducing fluid production in the eye, and in cases where eye drops are not sufficient, systemic medications such as carbonic bendy inhibitors are prescribed.
“These drugs are used as a temporary procedure for patients who suffer from high eye pressure and who need a rapid reduction in eye pressure to protect vision, but they should not be used if there is an allergy to sulfa or severe kidney disease. For patients who need additional intervention, the Hamad Foundation also provides an advanced laser treatment, traditional glucoma surgeries and new surgical interventions such as Preserflo Microshunt, which is a limited option to intervene for light to medium cases, ensuring high safety compared to traditional glucoma procedures designed to help drain fluid from the eye and reduce eye pressure, and in the most severe cases, we offer the cultivation of the PAUL glucoma, a new drainage device that provides effective and safe gogomoma to prevent more optic nerve damage, which ensures the best possible results For patients.